Updated project metadata.
The aim of the study is to discover and qualify serum protein biomarkers for cholangiocarcinoma diagnosis. Serum samples from normal, periductal fibrosis and CCA groups were screened using LC-MS/MS and MRM/MS as described in manuscript.